波利米辛B诱导的巴特特综合征
Bhavesh Mohan Lal1, Nimisha Musthafa Hafeesa1, Naval Kishore Vikram1
1Department of Medicine, All India Institute of Medical Sciences, New Delhi, Delhi, India.
获得的巴特特综合征可以是药物诱导的. 这份病例报告强调了聚素B诱导的毒性,导致巴特特综合征症状在药物戒断后消失,在药物重新引入后复发.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 临床药理学 临床药理学
- 遗传学 是一个遗传学.
背景情况:
- 巴特特综合征是一种遗传性疾病,具有代谢性,低血量,低磁性和高性.
- 获得的巴特特综合征可以由多胺和氨基糖化物等药物诱导.
- 聚米辛B和胆固醇蛋白 (聚米辛E) 在临床上使用,胆固醇蛋白更频繁地与毒性有关.
更多相关视频
07:38Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
08:505/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
Published on: July 3, 2013
相关概念视频
Antihypertensive Drugs: Potassium-Sparing Diuretics
Depolarizing Blockers: Pharmocokinetics
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
Drug Elimination by Renal Route: Tubular Secretion
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Although all competitive neuromuscular blockers are designed...
Drug Elimination by Renal Route: Tubular Reabsorption
